ADVB NASDAQ
Advanced Biomed Inc. Common Stock
1W: +5.5%
1M: -31.1%
3M: +32.5%
YTD: +11.4%
1Y: -24.9%
$6.73
-0.18 (-2.60%)
Weekly Expected Move ±11.1%
$5
$6
$7
$7
$8
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
$0
+100.0% ▲
Net Income
$0
+100.0% ▲
EPS (Diluted)
$-0.16
-23.1% ▼
EBITDA
$0
+100.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $2K | $4K | $12K | $13K | $0 |
| Gross Profit | -$2K | -$4K | -$12K | -$13K | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $2M | $2M | $1M | $880K | $0 |
| SG&A Expenses | $44K | $625K | $1M | $1M | $0 |
| Operating Expenses | $2M | $2M | $3M | $3M | $0 |
| Operating Income | -$2M | -$2M | -$3M | -$3M | $0 |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$2M | -$4M | -$4M | -$3M | $0 |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$2M | -$4M | -$4M | -$3M | $0 |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.16 | $-0.28 | $-0.19 | $-0.14 | $-0.16 |
| EBITDA | -$2M | -$2M | -$3M | -$2M | $0 |
| Shares Outstanding | 11M | 14M | 20M | 20M | 21M |